HEALY JAMES

Director at INTERMUNE INC · on record since Feb 24, 2006
10% owner at AERIE PHARMACEUTICALS INC · on record since Oct 30, 2013
Director at COTHERIX INC · on record since Jan 19, 2006
10% owner at COTHERIX INC · on record since Jan 19, 2006
Director at NOVACEA INC · on record since May 15, 2006
10% owner at NOVACEA INC · on record since May 15, 2006
Director at ArriVent Biopharma, Inc. · on record since Jan 31, 2024
10% owner at CORGENTECH INC · on record since Dec 21, 2007
10% owner at Anthera Pharmaceuticals Inc · on record since Dec 23, 2011
Director at Anthera Pharmaceuticals Inc · on record since Feb 23, 2010
10% owner at Trius Therapeutics Inc · on record since Aug 18, 2010
Director at AMARIN CORP PLC · on record since Dec 30, 2010
10% owner at AMARIN CORP PLC · on record since Dec 30, 2010
Director at Seaport Therapeutics, Inc. · on record since Apr 30, 2026
Director at Durata Therapeutics, Inc. · on record since Jul 25, 2012
10% owner at Durata Therapeutics, Inc. · on record since Jul 25, 2012
Director at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
10% owner at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
Director at KALOBIOS PHARMACEUTICALS INC · on record since Aug 10, 2012
10% owner at KALOBIOS PHARMACEUTICALS INC · on record since Aug 10, 2012
10% owner at ALIMERA SCIENCES INC · on record since Oct 4, 2012
10% owner at VERAMARK TECHNOLOGIES INC · on record since May 18, 2021
10% owner at TRANZYME INC · on record since Jul 17, 2013
10% owner at Versartis, Inc. · on record since Mar 28, 2014
Director at Rapport Therapeutics, Inc. · on record since Jun 10, 2026
10% owner at MARINUS PHARMACEUTICALS INC · on record since Jul 31, 2014
Director at BioAge Labs, Inc. · on record since Jun 12, 2026
Director at CHARMING SHOPPES INC · on record since Nov 12, 2014
10% owner at Ocugen, Inc. · on record since Dec 10, 2014
10% owner at One e Commerce CORP · on record since Jan 29, 2015
10% owner at Lifeline Systems, Inc. · on record since May 14, 2015
10% owner at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
Director at Edge Therapeutics, Inc. · on record since Sep 30, 2015
Director at Natera, Inc. · on record since Jul 9, 2015
10% owner at Aclaris Therapeutics, Inc. · on record since Oct 13, 2015
10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Feb 3, 2005
Director at Iterum Therapeutics plc · on record since May 30, 2018
10% owner at Iterum Therapeutics plc · on record since May 30, 2018
Director at Y-mAbs Therapeutics, Inc. · on record since Sep 25, 2018
10% owner at Entasis Therapeutics Holdings Inc. · on record since Sep 25, 2018
10% owner at Principia Biopharma Inc. · on record since Sep 20, 2018
Director at Karuna Therapeutics, Inc. · on record since Jun 27, 2019
10% owner at NextCure, Inc. · on record since May 15, 2019
10% owner at Galera Therapeutics, Inc. · on record since Nov 12, 2019
10% owner at Akouos, Inc. · on record since Jun 25, 2020
10% owner at Inozyme Pharma, Inc. · on record since Jul 28, 2020
10% owner at Checkmate Pharmaceuticals, Inc. · on record since Aug 12, 2020
Director at BOLT TECHNOLOGY CORP · on record since Feb 9, 2021
10% owner at Jade Biosciences, Inc. · on record since Jun 29, 2021
Director at CinCor Pharma, Inc. · on record since Jan 13, 2022
10% owner at CinCor Pharma, Inc. · on record since Jan 13, 2022

Insider trading activity of HEALY JAMES

Transactions on record: 424; since Jan 5, 2004

Open-market buys: 56; $168.3M

Open-market sells: 36; $120.3M

Companies traded: 22; last filing Jun 12, 2026

Figures computed from official regulatory filings — methodology.

Companies where HEALY JAMES has traded

BioAge Labs, Inc.2 tx · Jun 12, 2026
Rapport Therapeutics, Inc.21 tx · $10.6M · Jun 10, 2026
Seaport Therapeutics, Inc.4 tx · May 4, 2026
Y-mAbs Therapeutics, Inc.27 tx · $30M · Sep 18, 2025
Natera, Inc.52 tx · $54M · Apr 29, 2025
BOLT TECHNOLOGY CORP9 tx · $9M · Jun 14, 2024
Karuna Therapeutics, Inc.40 tx · $520.3M · Mar 18, 2024
ArriVent Biopharma, Inc.3 tx · $8M · Jan 31, 2024
CinCor Pharma, Inc.12 tx · $20.9M · Feb 27, 2023

Track record of HEALY JAMES

Statistical track record

Free

Open-market buys: 56

Last buy: Jul 1, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of HEALY JAMES

Co-insiders of HEALY JAMES

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
BioAge Labs, Inc.	Jun 12, 2026	AwardD	22,000	0.00 USD	$0	SEC
Rapport Therapeutics, Inc.	Jun 10, 2026	AwardD	15,200	0.00 USD	$0	SEC
Seaport Therapeutics, Inc.	May 4, 2026	Other	804,379	—	—	SEC
Seaport Therapeutics, Inc.	May 4, 2026	OtherD	-6,052,631	0.00 USD	$0	SEC
Seaport Therapeutics, Inc.	May 4, 2026	OtherD	-2,526,315	0.00 USD	$0	SEC
Seaport Therapeutics, Inc.	May 4, 2026	Other	1,927,159	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	Other	-2,194,278	8.60 USD	$18.9M	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-16,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-14,222	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	Other	-31,603	8.60 USD	$271.8K	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-33,450	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-13,950	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-11,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	Other	-25,080	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-11,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-14,545	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-8,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Jul 2, 2025	AwardD	33,450	0.00 USD	$0	SEC
Y-mAbs Therapeutics, Inc.	Jul 2, 2025	Award	25,080	0.00 USD	$0	SEC
Rapport Therapeutics, Inc.	Jun 18, 2025	AwardD	21,850	0.00 USD	$0	SEC
BioAge Labs, Inc.	Jun 9, 2025	AwardD	22,000	0.00 USD	$0	SEC
Natera, Inc.	Apr 29, 2025	Award	142	—	—	SEC
Natera, Inc.	Feb 4, 2025	Award	114	—	—	SEC
Natera, Inc.	Oct 29, 2024	Award	153	—	—	SEC
Natera, Inc.	Jul 30, 2024	Award	177	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
BioAge Labs, Inc.	Jun 12, 2026	AwardD	22,000	0.00 USD	$0	SEC
Rapport Therapeutics, Inc.	Jun 10, 2026	AwardD	15,200	0.00 USD	$0	SEC
Seaport Therapeutics, Inc.	May 4, 2026	Other	804,379	—	—	SEC
Seaport Therapeutics, Inc.	May 4, 2026	OtherD	-6,052,631	0.00 USD	$0	SEC
Seaport Therapeutics, Inc.	May 4, 2026	OtherD	-2,526,315	0.00 USD	$0	SEC
Seaport Therapeutics, Inc.	May 4, 2026	Other	1,927,159	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	Other	-2,194,278	8.60 USD	$18.9M	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-16,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-14,222	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	Other	-31,603	8.60 USD	$271.8K	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-33,450	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-13,950	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-11,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	Other	-25,080	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-11,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-14,545	—	—	SEC
Y-mAbs Therapeutics, Inc.	Sep 18, 2025	OtherD	-8,000	—	—	SEC
Y-mAbs Therapeutics, Inc.	Jul 2, 2025	AwardD	33,450	0.00 USD	$0	SEC
Y-mAbs Therapeutics, Inc.	Jul 2, 2025	Award	25,080	0.00 USD	$0	SEC
Rapport Therapeutics, Inc.	Jun 18, 2025	AwardD	21,850	0.00 USD	$0	SEC
BioAge Labs, Inc.	Jun 9, 2025	AwardD	22,000	0.00 USD	$0	SEC
Natera, Inc.	Apr 29, 2025	Award	142	—	—	SEC
Natera, Inc.	Feb 4, 2025	Award	114	—	—	SEC
Natera, Inc.	Oct 29, 2024	Award	153	—	—	SEC
Natera, Inc.	Jul 30, 2024	Award	177	—	—	SEC